Andrew Fein
Stock Analyst at HC Wainwright & Co.
(4.32)
# 401
Out of 4,502 analysts
406
Total ratings
52.06%
Success rate
15.81%
Average return
Main Sectors:
52 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRBP Corbus Pharmaceuticals Holdings | Reinstates: Buy | $80 | $54.46 | +46.90% | 3 | Jul 22, 2024 | |
| VIGL Vigil Neuroscience | Maintains: Buy | $24 → $17 | $4.25 | +300.00% | 8 | Jul 19, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $462 → $500 | $490.80 | +1.87% | 17 | Jul 19, 2024 | |
| KALV KalVista Pharmaceuticals | Reiterates: Buy | $20 | $14.47 | +38.22% | 10 | Jul 15, 2024 | |
| AMLX Amylyx Pharmaceuticals | Reiterates: Buy | $8 | $1.92 | +316.67% | 15 | Jul 10, 2024 | |
| LQDA Liquidia | Reiterates: Buy | $32 | $11.34 | +182.19% | 7 | Jul 10, 2024 | |
| INSM Insmed | Maintains: Buy | $70 → $90 | $74.43 | +20.92% | 8 | Jul 8, 2024 | |
| SVRA Savara | Maintains: Buy | $6 → $10 | $4.51 | +121.73% | 7 | Jun 27, 2024 | |
| WVE Wave Life Sciences | Reiterates: Buy | $15 | $6.15 | +143.90% | 6 | Jun 26, 2024 | |
| SYRS Syros Pharmaceuticals | Reiterates: Buy | $15 | $5.80 | +158.62% | 11 | Jun 26, 2024 | |
| ALEC Alector | Reiterates: Buy | $35 | $6.33 | +452.92% | 7 | Jun 20, 2024 | |
| ZNTL Zentalis Pharmaceuticals | Maintains: Buy | $40 → $20 | $4.31 | +364.04% | 13 | Jun 18, 2024 | |
| KROS Keros Therapeutics | Reiterates: Buy | $100 | $49.57 | +101.73% | 9 | Jun 18, 2024 | |
| KYMR Kymera Therapeutics | Reiterates: Buy | $46 | $42.88 | +7.28% | 6 | Jun 17, 2024 | |
| ANNX Annexon | Reiterates: Buy | $30 | $6.09 | +392.61% | 11 | Jun 4, 2024 | |
| TCRX TScan Therapeutics | Reiterates: Buy | $15 | $7.04 | +113.07% | 9 | Jun 4, 2024 | |
| CPRX Catalyst Pharmaceuticals | Reiterates: Buy | $26 | $17.51 | +48.49% | 10 | Jun 3, 2024 | |
| MRUS Merus | Maintains: Buy | $65 → $85 | $54.70 | +55.39% | 12 | May 29, 2024 | |
| BIIB Biogen | Reiterates: Buy | $300 | $226.03 | +32.73% | 14 | May 23, 2024 | |
| DYN Dyne Therapeutics | Maintains: Buy | $46 → $48 | $43.75 | +9.71% | 4 | May 20, 2024 | |
| ARVN Arvinas | Reiterates: Buy | $87 | $28.87 | +201.35% | 11 | May 17, 2024 | |
| PEPG PepGen | Reiterates: Buy | $26 | $17.56 | +48.06% | 7 | May 15, 2024 | |
| UBX Unity Biotechnology | Reiterates: Buy | $8 | $1.45 | +451.72% | 6 | May 15, 2024 | |
| ABOS Acumen Pharmaceuticals | Reiterates: Buy | $15 | $3.22 | +365.84% | 7 | May 15, 2024 | |
| STRO Sutro Biopharma | Reiterates: Buy | $12 | $3.89 | +208.48% | 9 | May 14, 2024 | |
| FULC Fulcrum Therapeutics | Reiterates: Buy | $17 | $8.56 | +98.60% | 11 | May 14, 2024 | |
| PRQR ProQR Therapeutics | Reiterates: Buy | $5 | $1.88 | +165.96% | 8 | May 10, 2024 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Buy | $33 → $27 | $18.48 | +46.10% | 14 | May 9, 2024 | |
| PRTA Prothena Corporation | Maintains: Buy | $90 → $84 | $23.97 | +250.44% | 10 | May 9, 2024 | |
| KMDA Kamada | Reiterates: Buy | $11 | $5.82 | +89.00% | 6 | May 9, 2024 | |
| DBVT DBV Technologies | Maintains: Buy | $20 → $10 | $0.96 | +942.64% | 9 | May 8, 2024 | |
| DNLI Denali Therapeutics | Reiterates: Buy | $95 | $23.61 | +302.37% | 11 | May 8, 2024 | |
| STOK Stoke Therapeutics | Reiterates: Buy | $35 | $14.28 | +145.10% | 8 | May 7, 2024 | |
| FHTX Foghorn Therapeutics | Reiterates: Buy | $20 | $6.25 | +220.00% | 11 | May 7, 2024 | |
| BCRX BioCryst Pharmaceuticals | Reiterates: Buy | $30 | $7.40 | +305.41% | 5 | May 7, 2024 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $2.32 | +891.38% | 10 | May 6, 2024 | |
| BPMC Blueprint Medicines | Maintains: Buy | $125 → $135 | $114.98 | +17.41% | 12 | May 3, 2024 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $150 → $160 | $145.88 | +9.68% | 8 | May 2, 2024 | |
| UTHR United Therapeutics | Reiterates: Buy | $300 | $331.59 | -9.53% | 8 | May 2, 2024 | |
| IMAB I-Mab | Reiterates: Buy | $18 → $8 | $1.41 | +467.38% | 8 | Mar 18, 2024 | |
| ACIU AC Immune | Reiterates: Buy | $16 | $3.53 | +353.26% | 9 | Mar 15, 2024 | |
| CCCC C4 Therapeutics | Maintains: Buy | $17 → $7 | $5.94 | +17.85% | 6 | Nov 2, 2023 | |
| PULM Pulmatrix | Reiterates: Buy | $10 | $2.10 | +376.19% | 5 | Aug 15, 2023 | |
| BLPH Bellerophon Therapeutics | Maintains: Buy | $30 → $2 | $0.05 | +3,821.57% | 4 | Jun 6, 2023 | |
| MEIP MEI Pharma | Maintains: Buy | $100 → $40 | $3.31 | +1,108.46% | 2 | Feb 13, 2023 | |
| MTNB Matinas BioPharma Holdings | Reiterates: Buy | $3 | $0.16 | +1,741.62% | 1 | Jan 31, 2023 | |
| ELOX Eloxx Pharmaceuticals | Maintains: Neutral | $40 → $20 | $0.70 | +2,757.14% | 4 | May 9, 2022 | |
| AMRN Amarin Corporation | Downgrades: Neutral | $10 → $3 | $0.78 | +282.46% | 1 | May 5, 2022 | |
| ALDX Aldeyra Therapeutics | Assumes: Buy | $15 | $3.91 | +283.63% | 1 | Apr 27, 2022 | |
| APRE Aprea Therapeutics | Maintains: Neutral | $80 → $40 | $3.87 | +933.59% | 3 | Mar 16, 2022 | |
| OCUP Ocuphire Pharma | Initiates: Buy | n/a | $1.99 | - | 1 | Nov 24, 2021 | |
| TBIO Telesis Bio | Maintains: Buy | $576 → $504 | $4.10 | +12,192.68% | 3 | Mar 18, 2021 |
Corbus Pharmaceuticals Holdings
Jul 22, 2024
Reinstates: Buy
Price Target: $80
Current: $54.46
Upside: +46.90%
Vigil Neuroscience
Jul 19, 2024
Maintains: Buy
Price Target: $24 → $17
Current: $4.25
Upside: +300.00%
Vertex Pharmaceuticals
Jul 19, 2024
Maintains: Buy
Price Target: $462 → $500
Current: $490.80
Upside: +1.87%
KalVista Pharmaceuticals
Jul 15, 2024
Reiterates: Buy
Price Target: $20
Current: $14.47
Upside: +38.22%
Amylyx Pharmaceuticals
Jul 10, 2024
Reiterates: Buy
Price Target: $8
Current: $1.92
Upside: +316.67%
Liquidia
Jul 10, 2024
Reiterates: Buy
Price Target: $32
Current: $11.34
Upside: +182.19%
Insmed
Jul 8, 2024
Maintains: Buy
Price Target: $70 → $90
Current: $74.43
Upside: +20.92%
Savara
Jun 27, 2024
Maintains: Buy
Price Target: $6 → $10
Current: $4.51
Upside: +121.73%
Wave Life Sciences
Jun 26, 2024
Reiterates: Buy
Price Target: $15
Current: $6.15
Upside: +143.90%
Syros Pharmaceuticals
Jun 26, 2024
Reiterates: Buy
Price Target: $15
Current: $5.80
Upside: +158.62%
Alector
Jun 20, 2024
Reiterates: Buy
Price Target: $35
Current: $6.33
Upside: +452.92%
Zentalis Pharmaceuticals
Jun 18, 2024
Maintains: Buy
Price Target: $40 → $20
Current: $4.31
Upside: +364.04%
Keros Therapeutics
Jun 18, 2024
Reiterates: Buy
Price Target: $100
Current: $49.57
Upside: +101.73%
Kymera Therapeutics
Jun 17, 2024
Reiterates: Buy
Price Target: $46
Current: $42.88
Upside: +7.28%
Annexon
Jun 4, 2024
Reiterates: Buy
Price Target: $30
Current: $6.09
Upside: +392.61%
TScan Therapeutics
Jun 4, 2024
Reiterates: Buy
Price Target: $15
Current: $7.04
Upside: +113.07%
Catalyst Pharmaceuticals
Jun 3, 2024
Reiterates: Buy
Price Target: $26
Current: $17.51
Upside: +48.49%
Merus
May 29, 2024
Maintains: Buy
Price Target: $65 → $85
Current: $54.70
Upside: +55.39%
Biogen
May 23, 2024
Reiterates: Buy
Price Target: $300
Current: $226.03
Upside: +32.73%
Dyne Therapeutics
May 20, 2024
Maintains: Buy
Price Target: $46 → $48
Current: $43.75
Upside: +9.71%
Arvinas
May 17, 2024
Reiterates: Buy
Price Target: $87
Current: $28.87
Upside: +201.35%
PepGen
May 15, 2024
Reiterates: Buy
Price Target: $26
Current: $17.56
Upside: +48.06%
Unity Biotechnology
May 15, 2024
Reiterates: Buy
Price Target: $8
Current: $1.45
Upside: +451.72%
Acumen Pharmaceuticals
May 15, 2024
Reiterates: Buy
Price Target: $15
Current: $3.22
Upside: +365.84%
Sutro Biopharma
May 14, 2024
Reiterates: Buy
Price Target: $12
Current: $3.89
Upside: +208.48%
Fulcrum Therapeutics
May 14, 2024
Reiterates: Buy
Price Target: $17
Current: $8.56
Upside: +98.60%
ProQR Therapeutics
May 10, 2024
Reiterates: Buy
Price Target: $5
Current: $1.88
Upside: +165.96%
ACADIA Pharmaceuticals
May 9, 2024
Maintains: Buy
Price Target: $33 → $27
Current: $18.48
Upside: +46.10%
Prothena Corporation
May 9, 2024
Maintains: Buy
Price Target: $90 → $84
Current: $23.97
Upside: +250.44%
Kamada
May 9, 2024
Reiterates: Buy
Price Target: $11
Current: $5.82
Upside: +89.00%
DBV Technologies
May 8, 2024
Maintains: Buy
Price Target: $20 → $10
Current: $0.96
Upside: +942.64%
Denali Therapeutics
May 8, 2024
Reiterates: Buy
Price Target: $95
Current: $23.61
Upside: +302.37%
Stoke Therapeutics
May 7, 2024
Reiterates: Buy
Price Target: $35
Current: $14.28
Upside: +145.10%
Foghorn Therapeutics
May 7, 2024
Reiterates: Buy
Price Target: $20
Current: $6.25
Upside: +220.00%
BioCryst Pharmaceuticals
May 7, 2024
Reiterates: Buy
Price Target: $30
Current: $7.40
Upside: +305.41%
Protara Therapeutics
May 6, 2024
Reiterates: Buy
Price Target: $23
Current: $2.32
Upside: +891.38%
Blueprint Medicines
May 3, 2024
Maintains: Buy
Price Target: $125 → $135
Current: $114.98
Upside: +17.41%
Neurocrine Biosciences
May 2, 2024
Maintains: Buy
Price Target: $150 → $160
Current: $145.88
Upside: +9.68%
United Therapeutics
May 2, 2024
Reiterates: Buy
Price Target: $300
Current: $331.59
Upside: -9.53%
I-Mab
Mar 18, 2024
Reiterates: Buy
Price Target: $18 → $8
Current: $1.41
Upside: +467.38%
AC Immune
Mar 15, 2024
Reiterates: Buy
Price Target: $16
Current: $3.53
Upside: +353.26%
C4 Therapeutics
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $5.94
Upside: +17.85%
Pulmatrix
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $2.10
Upside: +376.19%
Bellerophon Therapeutics
Jun 6, 2023
Maintains: Buy
Price Target: $30 → $2
Current: $0.05
Upside: +3,821.57%
MEI Pharma
Feb 13, 2023
Maintains: Buy
Price Target: $100 → $40
Current: $3.31
Upside: +1,108.46%
Matinas BioPharma Holdings
Jan 31, 2023
Reiterates: Buy
Price Target: $3
Current: $0.16
Upside: +1,741.62%
Eloxx Pharmaceuticals
May 9, 2022
Maintains: Neutral
Price Target: $40 → $20
Current: $0.70
Upside: +2,757.14%
Amarin Corporation
May 5, 2022
Downgrades: Neutral
Price Target: $10 → $3
Current: $0.78
Upside: +282.46%
Aldeyra Therapeutics
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $3.91
Upside: +283.63%
Aprea Therapeutics
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $3.87
Upside: +933.59%
Ocuphire Pharma
Nov 24, 2021
Initiates: Buy
Price Target: n/a
Current: $1.99
Upside: -
Telesis Bio
Mar 18, 2021
Maintains: Buy
Price Target: $576 → $504
Current: $4.10
Upside: +12,192.68%